CONcurrent ChEmotherapy and RadioTherapy in adjuvant treatment of breast cancer (CONCERT): a phase 2 study

PURPOSE: This phase 2 study evaluated the safety of adjuvant chemoradiation (CTRT) for breast cancer. METHODS: From April 2019 to 2020, 60 patients with stage II–III invasive breast cancer planned for adjuvant taxane-based chemotherapy and radiotherapy (RT) were accrued. Local ± regional (excluding...

Descripción completa

Detalles Bibliográficos
Autores principales: Wadasadawala, Tabassum, Anup, Akanksha, Carlton, Johnny, Sarin, Rajiv, Gupta, Sudeep, Parmar, Vani, Pathak, Rima, Ghosh, Jaya, Bajpai, Jyoti, Gulia, Seema, Krishnamurthy, Revathy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2023
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129380/
https://www.ncbi.nlm.nih.gov/pubmed/37113709
http://dx.doi.org/10.3332/ecancer.2023.1510

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129380/
https://www.ncbi.nlm.nih.gov/pubmed/37113709
http://dx.doi.org/10.3332/ecancer.2023.1510

Ejemplares similares